Table 3.
Logistic regression for salvageable recurrence
| Variable | Univariable | Multivariable | ||
|---|---|---|---|---|
| Odds ratio [95% CI] | P-value | Odds ratio [95% CI] | p-value | |
| Age at resection CRLM (cont.) | 0.986 [0.968–1.004] | 0.122 | ||
| ASA > II | 0.879 [0.470–1.642] | 0.685 | ||
| Right-sided primary | 0.416 [0.249–0.694] | 0.001* | 0.364 [0.211–0.628] | < 0.001* |
| pT3-4 | 0.534 [0.334–0.855] | 0.009* | 0.686 [0.409–1.151] | 0.153 |
| Node positive primary | 0.490 [0.336–0.715] | < 0.001* | 0.568 [0.375–0.860] | 0.008* |
| Disease free interval (cont.) | 1.011 [1.001–1.022] | 0.037* | 1.013 [1.003–1.024] | 0.014* |
| Number of CRLM (cont.) | 0.949 [0.880–1.023] | 0.171 | ||
| Diameter largest CRLM (cont.) | 0.932 [0.862–1.007] | 0.076 | 0.915 [0.842–0.994] | 0.036* |
| Preoperative CEA level (cont.) | 1.000 [0.999-1.000] | 0.270 | ||
| Preoperative chemotherapy | 1.210 [0.849–1.727] | 0.292 | ||
| R1 resection CRLM | 0.971 [0.607–1.554] | 0.903 | ||
| Extra hepatic disease | 0.864 [0.483–1.545] | 0.622 | ||
| Desmoplastic type tumours | 2.014 [1.295–3.132] | 0.002* | 2.370 [1.462–3.840] | < 0.001* |
*Indicates significant p-value
ASA American Society of Anaesthesiologists, CEA carcinoembryonic antigen, cont. continuous, CRLM colorectal liver metastases, R1 irradical resection margin